6-chloro-8-methyl-5-nitroquinoline | 27527-95-3

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 喹啉及其衍生物
• 英文名称: 6-chloro-8-methyl-5-nitroquinoline
• 英文别名: 6-chloro-8-methyl-5-nitro-quinoline；6-Chlor-8-methyl-5-nitro-chinolin；6-Chlor-8-methyl-5-nitrochinolin
• CAS: 27527-95-3
• 化学式: C₁₀H₇ClN₂O₂
• mdl: MFCD18448727
• 分子量: 222.631
• InChiKey: KKLDDPKYUWMGOW-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3
• 重原子数：
  15
• 可旋转键数：
  0
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.1
• 拓扑面积：
  58.7
• 氢给体数：
  0
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  6-chloro-8-methyl-5-nitroquinoline 在 sodium hydroxide 、 镍 、 丙酮 作用下， 生成 N-(6-chloro-8-methyl-[5]quinolyl)-benzamide
  参考文献：
  名称：

  Some Derivatives of 6-Bromo-8-methylquinoline and 6-Chloro-8-methylquinoline¹

  摘要：

  DOI：

  10.1021/ja01165a063
• 作为产物：
  描述：

  4-氯-2-甲基苯胺 在 硫酸 、 硝酸 作用下， 以 硝基苯 为溶剂， 反应 9.0h， 生成 6-chloro-8-methyl-5-nitroquinoline
  参考文献：
  名称：

  [EN] 5-AMINO-QUINOLINE-8-CARBOXAMIDE DERIVATIVES AS 5-HT4 RECEPTOR AGONISTS
  [FR] DÉRIVÉS 5-AMINO-QUINOLINE-8-CARBOXAMIDES EN TANT QU'AGONISTES DU RÉCEPTEUR 5-HT4

  摘要：

  公开号：

  WO2014147636A8

文献信息

• HETEROARYL COMPOUNDS AND METHODS OF USE THEREOF
  申请人：Campbell John Emmerson

  公开号：US20130158003A1

  公开（公告）日：2013-06-20

  Provided herein are heteroaryl compounds, methods of their synthesis, pharmaceutical compositions comprising the compounds, and methods of their use. In one embodiment, the compounds provided herein are useful for the treatment, prevention, and/or management of various disorders, such as CNS disorders and metabolic disorders, including, but not limited to, e.g., neurological disorders, psychosis, schizophrenia, obesity, and diabetes.

  本文提供了杂环芳基化合物、其合成方法、包含该化合物的药物组合物以及使用该化合物的方法。在一种实施例中，本文提供的化合物可用于治疗、预防和/或管理各种疾病，例如中枢神经系统疾病和代谢性疾病，包括但不限于神经系统疾病、精神病、精神分裂症、肥胖症和糖尿病。
• Substituted quinoxalines and quinoxalinones as PDE-10 inhibitors
  申请人：Campbell John Emmerson

  公开号：US08969349B2

  公开（公告）日：2015-03-03

  Provided herein are compounds of formula A-L-B, and pharmaceutically acceptable salts and stereoisomers thereof, wherein A is R1 and R2 together with the carbon atoms to which they are attached form a 1,2-phenylene ring optionally substituted with one or more R11; L is —C(R6)2—C(R6)2—; B is a heteroaromatic group defined herein; and -A1-A2- , A3, R11 and R6 are defined herein. Also disclosed are methods of their synthesis, pharmaceutical compositions comprising the compounds, and methods of their use. In one embodiment, the compounds provided herein are useful for the treatment, prevention, and/or management of various disorders, such as CNS disorders and metabolic disorders, including, but not limited to, e.g., neurological disorders, psychosis, schizophrenia, obesity, and diabetes.

  本文提供了A-L-B式化合物及其药学上可接受的盐和立体异构体，其中A为R1和R2，与它们连接的碳原子形成一个可选择地取代一个或多个R11的1,2-苯撑环；L为—C（R6）2—C（R6）2—；B为在本文中定义的杂环芳基；-A1-A2-、A3、R11和R6在本文中定义。还披露了它们的合成方法、包含这些化合物的药物组合物以及它们的使用方法。在一个实施例中，本文提供的化合物可用于治疗、预防和/或管理各种疾病，如中枢神经系统疾病和代谢性疾病，包括但不限于神经系统疾病、精神病、精神分裂症、肥胖症和糖尿病。
• Heteroaryl Compounds and Methods of Use Thereof
  申请人：SUNOVION PHARMACEUTICALS INC.

  公开号：US20150166571A1

  公开（公告）日：2015-06-18

  Provided herein are heteroaryl compounds, methods of their synthesis, pharmaceutical compositions comprising the compounds, and methods of their use. In one embodiment, the compounds provided herein are useful for the treatment, prevention, and/or management of various disorders, such as CNS disorders and metabolic disorders, including, but not limited to, e.g., neurological disorders, psychosis, schizophrenia, obesity, and diabetes.

  本文提供了杂环芳基化合物、它们的合成方法、包含这些化合物的药物组合物以及它们的使用方法。在一种实施方式中，本文提供的化合物可用于治疗、预防和/或管理各种疾病，例如中枢神经系统疾病和代谢性疾病，包括但不限于神经系统疾病、精神病、精神分裂症、肥胖症和糖尿病等。
• Substituted quinoxalines as PDE-10 inhibitors
  申请人：SUNOVION PHARMACEUTICALS INC.

  公开号：US10562916B2

  公开（公告）日：2020-02-18

  Provided herein are cyclic nucleotide phosphodiesterase inhibitors, and pharmaceutical compositions thereof, useful for the treatment of, for example, central nervous system and metabolic diseases and disorder.

  本文提供了环核苷酸磷酸二酯酶抑制剂及其药物组合物，可用于治疗中枢神经系统和代谢疾病及紊乱等。
• 8-amino-6-(arylsulphonyl)-5-nitroquinolines: novel nonpeptide neuropeptide Y1 receptor antagonists
  作者：Jon Wright、Gary Bolton、Mark Creswell、Dennis Downing、Lynn Georgic、Thomas Heffner、John Hodges、Robert MacKenzie、Lawrence Wise

  DOI：10.1016/0960-894x(96)00319-8

  日期：1996.8

  A novel series of 8-amino-6-(arylsulphonyl)-5-nitroquinoline neuropeptide Y1 (NPY) receptor antagonists is reported. The 8-amino and 5-nitro groups were important for NPY1 binding affinity as changes caused large drops in potency. The 6-arylsulphonyl group was necessary; however, substitution on the phenyl was tolerated. The 2-isopropyl analog 21 was a moderately potent, highly selective NPY1 receptor antagonist. Copyright (C) 1996 Elsevier Science Ltd